TEHRAN – The head of the Atomic Energy Organization of Iran on Sunday hailed remarkable feats in nuclear medicine technologies, saying many high-tech products are being exported, including radiopharmaceuticals.
Speaking to reporters on the sidelines of the 29th Iranian Nuclear Conference here, Muhammad Eslami said local nuclear scientists have made impressive achievements during the current Iranian year, which will end on March 20.
Iran, he said, has managed to develop a blood clotting powder used for controlling hemorrhage in major surgeries, noting that the country was deprived of such medical item due to the foreign sanctions.
The Food and Drug Administration of Iran has approved the powder, which can be exported to the other countries, Eslami added.
He also praised Iran’s nuclear scientists for inventing a new method for the treatment of garbage leachate with plasma technologies.
He touched on efforts being made to create more opportunities for research in the nuclear technologies, saying Iranian radiopharmaceuticals and nuclear medicine equipment are now being exported to the other countries.
In December 2022, the AEOI chief said Iran aims to become a global hub for manufacturing deuterium drugs.
“In a not too distant future we will turn into a hub for manufacturing drugs based on deuterium which are good alternatives to chemical drugs and have lower side effects in comparison (to those drugs),” he said.
The AEOI launched a second phase of its deuterium production unit in Arak Heavy Water Reactor Facility in central Iran in April 2021.